Pharma Innovation And NHS Dodge Axe In U.K. Spending Review, But There Is A Price To Pay

Science R&D spending will be maintained at current levels but amount to be allocated for pharmaceuticals unclear.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet